Recent studies suggest a potential link between hormone therapy and Alzheimer's disease and dementia. Hormone therapy, particularly estrogen, has been explored due to its role in brain health and cognitive function. Estrogen is believed to have neuroprotective effects, potentially reducing the risk of developing Alzheimer's disease by maintaining neuronal health and synaptic function. However, the relationship is complex, as hormone therapy's benefits may depend on various factors such as the timing of treatment initiation and duration. Some studies indicate that starting hormone therapy around the onset of menopause might be more beneficial for cognitive outcomes than starting later in life. Nonetheless, more research is needed to fully understand the effects of hormone therapy on Alzheimer's disease and dementia, including its long-term risks and benefits.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States